UK says it will monitor AI-based medical devices continually

By Bhanvi Satija

LONDON, ‌Oct 6 (Reuters) - ​AI-based ​medical devices will need constant monitoring even after they're approved for use, rather ‌than a single pre-approval safety check, the head ⁠of the UK's medicines regulator said on Tuesday.

The UK ‌government will accept all ‌44 recommendations from a report on how such AI tools are approved, it said.

• The government ​commits to publishing a full implementation plan by spring 2027, with a draft plan expected ⁠by the end of the year

• The plan will spell out ​delivery targets and timelines for putting each change into place across the NHS

• Britain ​is the first country to ‌develop comprehensive rules for this emerging technology

• Lawrence Tallon, Medicines and Healthcare ⁠products Regulatory Agency Chief Executive, told Reuters many nations are now approaching the UK to learn from its ⁠approach

• "We're moving into a much more sophisticated and complex era ​of AI as a medical device where we have non-deterministic algorithms," he said, referring to AI systems that evolve ‌and adapt while doctors are using them

• The MHRA will also start ‌accepting applications for the third phase of its ⁠AI Airlock program, focusing ‌on post-market surveillance ​and lifecycle monitoring after devices enter clinical practice

(Reporting by Bhanvi Satija, Editing by Rosalba ‌O'Brien)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cornell students stage anti-rape rally
• Russia says Ukraine hit two facilities at Zaporizhzhia nuclear plant
• New Zealand third quarter business confidence jumps, says think tank